skinconsidered
Newsletter
Menu
Coverage / a map, not a claim of completeness

What we track, and what we do not yet.*

Skincare developments surface across dozens of regulators, journals, and societies. This page shows the taxonomy we file them under, the jurisdictions currently on file, and which sources are actually cited versus only watched.

20dispatches on file
10jurisdictions with at least one file
45procedure files
18/30registry sources cited in a current file
01 / Taxonomy

9 desks. One filing system.

A development is filed by what it is, not by who announced it. The list under each desk is the scope we aim to cover; it is not a claim that every item in scope has been reported.

In the Routine

Celebrity skincare with dated, first-person sources and independent context.

  • Products identified in original recordings
  • Known brand relationships and source dates
  • Personal experience kept separate from clinical evidence

Regulation

Changes in what may be sold, claimed, or listed, and where.

  • Premarket approvals and orders (sunscreen filters, drugs, devices)
  • Ingredient restrictions, bans, and safety opinions
  • Labeling, claims, and advertising rules
  • Registration and product listing (for example MoCRA)
  • Consultations and proposed rules, marked as proposals

Safety

Actions and signals about products already on the market.

  • Recalls and market withdrawals
  • Safety communications and consumer warnings
  • Adverse-event signals, marked as signals rather than rates
  • Enforcement, warning letters, and counterfeit or unapproved products
  • Contamination, adulteration, and undeclared ingredients

Research

Human evidence and what it can support.

  • Randomized and controlled trials
  • Systematic reviews and meta-analyses
  • Observational and mechanistic studies, graded accordingly
  • Trial registrations and results postings
  • Funding, conflicts, and replication status

Procedures

Treatments performed on people, from spa facials to resurfacing.

  • Facials and spa-grade treatments
  • Peels and exfoliation by depth
  • Injectables: neuromodulators, fillers, biostimulators, boosters, fat-dissolving drugs
  • Energy devices: lasers, light, ultrasound, radiofrequency, needling, electromagnetic
  • Body contouring, hair and scalp, and energy-based intimate devices
  • Facial surgery families compared against their non-surgical alternatives
  • Complication reporting, cost context, and use statistics with caveats

Topicals

Prescription, over-the-counter, and cosmetic ingredients people are actually using.

  • U.S. status: prescription, OTC drug, or cosmetic
  • Strengths and forms as sold, with generic availability
  • Evidence graded per use, never per ingredient
  • How to use, side effects, pregnancy and interaction cautions
  • Regional rules where they differ from the U.S.

Trends

What people are doing, what they are told it does, and what the evidence supports.

  • Routines (slugging, skin cycling, flooding)
  • Trending ingredients and devices
  • Supplements marketed for skin
  • Safety verdicts, with 'Avoid' reserved for documented harm
  • Where a trend touches a procedure or prescription

Guides

Durable explainers written to the evidence ceiling.

  • Routine building and barrier care
  • Ingredient decisions such as retinoids
  • Procedure safety checklists
  • How to read a claim, a label, or a study

Culture

Beauty practices in their historical and material context.

  • Museum, archive, and scholarly sources
  • Material and technological history
  • Practices described without 'ancient secret' framing
  • Modern claims traced back to their origins
02 / Jurisdictions on file

Where current dispatches come from.

Computed from the files themselves. A jurisdiction that is absent here is not covered yet, whatever the registry below intends.

JurisdictionRegionFilesDesksLatest
United StatesNorth America6Safety, Regulation
CanadaNorth America2Safety
BrazilLatin America1Safety
European UnionEurope2Regulation, Safety
United KingdomEurope2Safety
GermanyEurope1Research
SingaporeAsia2Safety
TaiwanAsia2Safety, Procedures
AustraliaOceania1Regulation
United Kingdom / international trialsGlobal1Research
03 / Source registry

18 sources in use, 12 on the watchlist.

“In use” means at least one source link on file matches this registry entry. Each link is counted against the most specific registered domain, so a specialist subdomain is not also counted under its parent. Counts include repeated citations across files, not just unique URLs. “Watchlist” means no matching citation is on file. Cadence is the intended check schedule, not a log of checks completed.

United States and Canada

Europe

Asia

Oceania

Latin America

Global

04 / How a source becomes a file

Six steps, no shortcuts.

The full workflow is in the methodology. The gates run on every build.

  1. 01 RegistryEvery source we intend to check is listed below with its jurisdiction, what it can establish, and the intended check cadence.
  2. 02 ScanRegulators and safety feeds first, then indexed literature and society guidance. Press coverage can point to a story but never replaces the record.
  3. 03 Claim ledgerEach proposed headline gets the exact claim, the source and its date, the population or jurisdiction, the comparator, conflicts, and the strongest limitation.
  4. 04 Draft to the ceilingA proposal stays a proposal. A signal stays a signal. A product trial does not become an ingredient verdict. The grade travels with the claim.
  5. 05 GatesThe content audit blocks prototype copy, hype phrases, missing sources or limitations, broken cross links, and date mismatches before a build can succeed.
  6. 06 Review and updateEvery file carries its review date. A status change becomes a dated update or correction on the file and on the corrections log, never a silent rewrite.
Limitations

What this page does not claim.